Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Sanderson

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Gastrohep|December 28, 2020
The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centreEsha Sharma, Susanna Meade, Francesca D'Errico, et al.
Frontiers in Cell and Developmental Biology|October 5, 2018
Validating the RedMIT/GFP-LC3 Mouse Model by Studying Mitophagy in Autosomal Dominant Optic Atrophy Due to the OPA1Q285STOP MutationAlan Diot, Thomas Agnew, Jeremy Sanderson, et al.
Inflammatory Bowel Diseases|November 22, 2011
Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiotaJane L Benjamin, Charlotte R H Hedin, Andreas Koutsoumpas, et al.
Ebiomedicine|February 8, 2025
A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's diseaseJeremy Sanderson, Jeremy Aboagye, Rebecca Makinson, et al.
Gastroenterology|May 9, 2007
IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel diseaseMark Tremelling, Fraser Cummings, Sheila A Fisher, et al.
Human Molecular Genetics|January 29, 2010
Independent and population-specific association of risk variants at the IRGM locus with Crohn's diseaseNatalie J Prescott, Katherine M Dominy, Michiaki Kubo, et al.
Frontline Gastroenterology|August 26, 2017
Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centresMark A Samaan, Polychronis Pavlidis, Emma Johnston, et al.
Development (Cambridge, England)|October 9, 2014
ATMIN is a transcriptional regulator of both lung morphogenesis and ciliogenesisParaskevi Goggolidou, Jonathan L Stevens, Francesco Agueci, et al.
Gastroenterology|November 8, 2006
Genetic variation in myosin IXB is associated with ulcerative colitisAdriaan A van Bodegraven, Christine R Curley, Karen A Hunt, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2019
Mice with a Brd4 Mutation Represent a New Model of NephrocalcinosisCaroline M Gorvin, Nellie Y Loh, Michael J Stechman, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Gastrohep|December 28, 2020
The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centreEsha Sharma, Susanna Meade, Francesca D'Errico, et al.
Frontiers in Cell and Developmental Biology|October 5, 2018
Validating the RedMIT/GFP-LC3 Mouse Model by Studying Mitophagy in Autosomal Dominant Optic Atrophy Due to the OPA1Q285STOP MutationAlan Diot, Thomas Agnew, Jeremy Sanderson, et al.
Inflammatory Bowel Diseases|November 22, 2011
Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiotaJane L Benjamin, Charlotte R H Hedin, Andreas Koutsoumpas, et al.
Ebiomedicine|February 8, 2025
A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's diseaseJeremy Sanderson, Jeremy Aboagye, Rebecca Makinson, et al.
Gastroenterology|May 9, 2007
IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel diseaseMark Tremelling, Fraser Cummings, Sheila A Fisher, et al.
Human Molecular Genetics|January 29, 2010
Independent and population-specific association of risk variants at the IRGM locus with Crohn's diseaseNatalie J Prescott, Katherine M Dominy, Michiaki Kubo, et al.
Frontline Gastroenterology|August 26, 2017
Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centresMark A Samaan, Polychronis Pavlidis, Emma Johnston, et al.
Development (Cambridge, England)|October 9, 2014
ATMIN is a transcriptional regulator of both lung morphogenesis and ciliogenesisParaskevi Goggolidou, Jonathan L Stevens, Francesco Agueci, et al.
Gastroenterology|November 8, 2006
Genetic variation in myosin IXB is associated with ulcerative colitisAdriaan A van Bodegraven, Christine R Curley, Karen A Hunt, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2019
Mice with a Brd4 Mutation Represent a New Model of NephrocalcinosisCaroline M Gorvin, Nellie Y Loh, Michael J Stechman, et al.
Pageof 8